Search Results - Standard Search:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov

PubPharm (448)

1

(A Little) Clarity on Convalescent Plasma for Covid-19

in: The New England journal of medicine | (13.01.2021)

by Katz, L.

2

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

in: The New England journal of medicine | (13.01.2021)

by Sadoff, J. | Le Gars, M. | Shukarev, G. | +24

3

The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 7-9

by Rosenquist, J.

4

Lessons We've Learned - Covid-19 and the Undocumented Latinx Community

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 5-7

by Page, K. | Flores-Miller, A.

5

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 80-82

by Widge, A. | Rouphael, N. | Jackson, L. | +255

6

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 20-30

by Salama, C. | Han, J. | Yau, L. | +17

7

Tocilizumab in Covid-19

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 86-87

by Leaf, D. | Gupta, S. | Wang, W.

CommentOn: N Engl J Med. 2020 Dec 10;383(24):2333-2344. - PMID 33085857

8

Tocilizumab in Covid-19. Reply

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. 87

by Stone, J. | Horick, N. | Healy, B.

CommentOn: N Engl J Med. 2021 Jan 7;384(1):86-87. - PMID 33356049

9

Audio Interview : Planning for the SARS-CoV-2 Vaccine Rollout

in: The New England journal of medicine | Vol. 384, No. 1 (2021), p. e13

by Rubin, E. | Baden, L. | Lee, T. | +1

10

Beyond Politics - Promoting Covid-19 Vaccination in the United States

in: The New England journal of medicine | (06.01.2021)

by Wood, S. | Schulman, K.

1
2
3
4
5
6
7
8
9
10
11
Next »
[45]